new glp-1 retatrutide Extreme Side Effects Followed Overdose of Unapproved Weight-Loss Drug Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

Participants with HbA1c level ranging from 7%11% were randomized to receive daily liraglutide (1.8 mg) after a titration period of once-weekly liraglutide (0.6 mg), once-weekly (1.2 mg) for 2 weeks, or 5 g of exenatide twice daily for 4 weeks

J Am Acad Dermatol 78(6):10901096

The choice often comes down to individual response, tolerability, and cost

The hashtag #wegovyweightloss had 163.2 million views as of September 1, 2023, influencing younger generations to use the drug for weight loss, while leaving them unaware of potential long-term side effects

doi: 10.1186/s12933-021-01366-8 88 LeeMMYKristensenSLGersteinHCMcMurrayJJVSattarN

It activates both GLP-1 and GIP receptors, while Wegovy and Ozempic focus solely on GLP-1, making Mounjaro a unique injection